CUSIP: 29286X101 | NYSE | Healthcare · Biotechnology | Micro Cap | 60 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13G/ARaymond Debbane with Invus Global Management, LLC, Siren, L.L.C., Invus Public Equities, L.P., +4 more | 6,256,662 | 9.3% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| 13G/ABlue Owl Capital Holdings LP |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 1,038,617 | $2.1M | 1.5% | Deep Value | Medium | Bedford Hills, NY | 2026-10-22 | |
| 170,000 | $340.0K | 0.1% | Growth | Medium | Amsterdam, Philippines | 2026-11-03 | |
| 40,000 | $80.0K | 0.0% | ETF | Very Low | Mine Hill, NJ | 2026-10-21 | |
| 38,291 | $76.6K | 0.0% | Index | Low | Austin, TX | 2026-11-04 | |
| 29,446 | $58.9K | 0.0% | Growth | Medium | Clearwater, FL | 2026-10-26 | |
| 21,451 | $43.0K | 0.1% | Value | High | London, United Kingdom | 2026-10-30 | |
| 5,025 | $10.1K | 0.0% | Core | Very High | Chicago, IL | 2026-11-04 | |
| 492 | $984 | 0.0% | Core | Medium | New York, NY | 2026-11-04 | |
| 278 | $556 | 0.0% | Deep Value | Very High | Chicago, IL | 2026-11-02 | |
| 100 | $200 | 0.0% | Index | Low | San Francisco, CA | 2026-10-08 | |
| 28 | $56 | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2026-10-22 |
| 511,177 |
| 0.8% |
| Newly reported |
| Jun 30, 2026 |
| Not yet in a 13F |
| 13G/ADeep Track Biotechnology Master Fund, Ltd. | 0 | 0.0% | No shares held | Jun 30, 2026 | No 13F filer matched |